Published in Gene Therapy Weekly, May 9th, 2002
This study, being led by Dr. Michael Konstan, aims to use gene transfer technologies to provide a normal copy of the CF gene to correct the underlying defect. The mutations of this gene are the root cause of the disease. This trial is the first...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.